Particle.news

Download on the App Store

Teddi Mellencamp Faces Stage 4 Melanoma with 50/50 Survival Odds

The reality star discusses her ongoing battle with metastatic cancer, recent treatments, and emotional struggles as she begins a new phase of immunotherapy.

  • Teddi Mellencamp, 43, has completed radiation treatment and is starting five rounds of immunotherapy for stage 4 melanoma that has spread to her brain and lungs.
  • Doctors have given her a '50/50' chance of survival, citing the limited history of immunotherapy, which has been in use for only a decade.
  • Mellencamp has undergone multiple surgeries, including the removal of brain tumors, during which additional tumors were discovered in her lungs.
  • She has openly shared her emotional challenges, expressing fear and a sense of lost control, while also using humor to cope with her diagnosis.
  • Her public reflections and discussions, including light-hearted moments with her family, have brought attention to the personal and medical complexities of advanced cancer treatment.
Hero image